So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

US President Donald Trump on May 23 threatened to impose a 50 percent tariff on all imports from the European Union.

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth ...

How pharmaceutical tariffs could reshape drug pricing, supply chains and domestic production in the United States, according ...

Notably, the U.S.’ two primary biopharma trade groups—the Pharmaceutical Research and Manufacturers of America (PhRMA) and ...

In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, ...

While the Trump administration’s threat of pharmaceutical import tariffs and most favored nation (MFN) drug pricing has ...

U.S. dependency on China for critical goods like rare earths and pharmaceuticals poses risks. Trump's strategies aim to ...

US President Donald Trump’s tariff decisions since he took office on Jan 20 have given investors and political leaders alike ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed ...